Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0

Fujun Hou, Zeyu Sun, Yue Deng, Siyu Chen, Xiyuan Yang, Feiyang Ji, Menghao Zhou, Keyi Ren, Dongli PanFrontiers in Microbiology 2022 · DOI

TL;DR

This study uses advanced proteomic techniques (interactome and ubiquitinome analysis) to identify novel cellular targets of the Herpes Simplex Virus 1 (HSV-1) protein ICP0, particularly in neuronal cells. They found that ICP0 targets proteins like SNX9, which restricts viral replication, and OTUD4, which enhances the host's antiviral interferon response, revealing new insights into how HSV-1 manipulates host cells.

What Problem Does This Paper Address?

Herpes Simplex Virus 1 (HSV-1) is a common human pathogen that can cause both acute infections and establish lifelong latency, particularly in neurons. A key viral protein, ICP0, acts as an E3 ubiquitin ligase, playing a critical role in viral replication and reactivation from latency. While ICP0's function is known to be crucial, its specific cellular targets, especially within the complex environment of neuronal cells, remain largely unknown. Understanding these targets is vital for deciphering how HSV-1 evades host defenses and establishes infection. This paper aims to bridge this knowledge gap by comprehensively identifying and functionally characterizing ICP0's targets in neuronal cells.

Methods

The researchers employed a multi-pronged approach combining proteomics and functional assays.

  • Interactome Analysis: They used mass spectrometry-based interactome analysis to identify proteins that physically bind to ICP0. This involved infecting various cell types (Neuro-2a, 293T, and human foreskin fibroblasts) with a Flag-tagged ICP0 virus and then performing co-immunoprecipitation (Co-IP) with an anti-Flag antibody, followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify bound proteins.
  • Ubiquitinome Analysis: To identify ICP0's substrates (proteins it ubiquitinates), they performed quantitative ubiquitinome analysis. This involved comparing the ubiquitination profiles of cells infected with an ICP0-null virus versus cells infected with ICP0-expressing virus or transfected with ICP0. They enriched for ubiquitinated peptides using a di-glycine antibody and analyzed them by TMT-labeled LC-MS/MS.
  • Validation: Promising interactors and potential substrates were validated using reverse Co-IP experiments and Western blotting.
  • Functional Assays: The functional roles of identified targets were investigated using overexpression and knockdown (siRNA) experiments to assess their impact on HSV-1 replication and type I interferon (IFN) production.

Datasets

Not explicitly detailed as distinct datasets for training/evaluation in the context of machine learning. The primary "datasets" are the proteomic data generated from the mass spectrometry experiments on infected cell lysates.

Key Insights and Ideas

  • Neuronal Cell Specificity: The study highlights that ICP0's interactome can differ significantly between mouse neuronal cells (Neuro-2a) and human cell lines, suggesting cell-type-specific mechanisms of viral manipulation.
  • SNX9 as a Restriction Factor: The identification of Sorting Nexin 9 (SNX9) as an ICP0 interactor and its subsequent functional validation revealed that SNX9 can restrict HSV-1 replication, particularly in neuronal cells, and this restriction is dependent on ICP0's presence.
  • OTUD4's Role in Antiviral Defense: Ovarian tumour domain-containing protein 4 (OTUD4) was identified as a novel ICP0 target and was found to be upregulated during HSV-1 infection independently of ICP0. Crucially, OTUD4 enhances type I interferon expression, a key antiviral defense mechanism, and this enhancement is blocked by ICP0.
  • Ubiquitination vs. Degradation: The study found that while OTUD4 and Vimentin (VIM) are ubiquitinated by ICP0, this ubiquitination does not necessarily lead to their degradation, suggesting alternative regulatory roles for ICP0-mediated ubiquitination.
  • Dual Proteomic Approach Power: Combining interactome and ubiquitinome analyses proved powerful in identifying high-confidence ICP0 targets, particularly those involved in both binding and modification.

Key Results

  • ICP0-null HSV-1 showed significantly impaired replication in primary mouse neurons and Neuro-2a cells compared to wild-type virus.
  • Interactome analysis identified a total of 108 candidate ICP0-interacting proteins across Neuro-2a, 293T, and HFF cells.
  • Co-immunoprecipitation confirmed interactions between ICP0 and ACOT8, C1QBP, OTUD4, SNX9, and VIM.
  • Knockdown of SNX9 in Neuro-2a cells significantly increased the replication of ICP0-null HSV-1, indicating SNX9's restrictive role.
  • Ubiquitinome analysis identified numerous candidate ubiquitination substrates of ICP0, with OTUD4 and VIM confirmed as novel substrates.
  • Overexpression of OTUD4 enhanced type I interferon expression during infection with ICP0-null virus, but this effect was blocked in the presence of functional ICP0.

Limitations and Future Work

  • Neuronal Cell Model: The study primarily used the Neuro-2a cell line, a mouse neuronal cell line. The authors acknowledge that these interactions may not perfectly represent those occurring in non-dividing human neurons, which are the natural hosts for HSV-1. Future studies are needed to examine these interactions in human neurons.
  • Mouse vs. Human Differences: The poor overlap in interactome data between mouse Neuro-2a cells and human cell lines suggests potential species-specific differences in ICP0 targets, which warrants further investigation.
  • Mechanism of SNX9 and OTUD4: While SNX9's restrictive role and OTUD4's IFN-enhancing role were demonstrated, the precise molecular mechanisms by which they exert these functions and how ICP0 modulates them require further elucidation. For instance, the specific pathway through which SNX9 restricts HSV-1 entry needs to be explored.
  • VIM's Role: The study found no evidence of VIM regulating HSV-1 replication or IFN expression, despite its interaction with ICP0. Its potential role in inflammation and inflammasome activation, as suggested by other literature, warrants further investigation in the context of viral infection.
  • Transient Interactions: The authors note that some interactions might be too transient to be captured by immunoprecipitation, and some ubiquitination events might occur without detectable binding.

Summary updated

Abstract

Herpes simplex virus 1 (HSV-1) can productively infect multiple cell types and establish latent infection in neurons. Infected cell protein 0 (ICP0) is an HSV-1 E3 ubiquitin ligase crucial for productive infection and reactivation from latency. However, our knowledge about its targets especially in neuronal cells is limited. We confirmed that, like in non-neuronal cells, ICP0-null virus exhibited major replication defects in primary mouse neurons and Neuro-2a cells. We identified many ICP0-interacting proteins in Neuro-2a cells, 293T cells, and human foreskin fibroblasts by mass spectrometry-based interactome analysis. Co-immunoprecipitation assays validated ICP0 interactions with acyl-coenzyme A thioesterase 8 (ACOT8), complement C1q binding protein (C1QBP), ovarian tumour domain-containing protein 4 (OTUD4), sorting nexin 9 (SNX9), and vimentin (VIM) in both Neuro-2a and 293T cells. Overexpression and knockdown experiments showed that SNX9 restricted replication of an ICP0-null but not wild-type virus in Neuro-2a cells. Ubiquitinome analysis by immunoprecipitating the trypsin-digested ubiquitin reminant followed by mass spectrometry identified numerous candidate ubiquitination substrates of ICP0 in infected Neuro-2a cells, among which OTUD4 and VIM were novel substrates confirmed to be ubiquitinated by transfected ICP0 in Neuro-2a cells despite no evidence of their degradation by ICP0. Expression of OTUD4 was induced independently of ICP0 during HSV-1 infection. Overexpressed OTUD4 enhanced type I interferon expression during infection with the ICP0-null but not wild-type virus. In summary, by combining two proteomic approaches followed by confirmatory and functional experiments, we identified and validated multiple novel targets of ICP0 and revealed potential restrictive activities of SNX9 and OTUD4 in neuronal cells.
BibTeX
@inproceedings{hou2022interactome,
  author = {Fujun Hou and Zeyu Sun and Yue Deng and Siyu Chen and Xiyuan Yang and Feiyang Ji and Menghao Zhou and Keyi Ren and Dongli Pan},
  title = {{Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0}},
  booktitle = {Frontiers in Microbiology},
  year = {2022},
  doi = {10.3389/fmicb.2022.856471},
}
Figure